iShares MSCI Denmark ETFEDEN

EDEN, the iShares MSCI Denmark ETF, is a wrapper designed to deliver the broad Danish equity market through the MSCI Denmark Index, not a high-octane AI rocket ship as its marketing suggests. The fund’s top holdings-Novo Nordisk, Danske Bank, and Vestas Wind Systems-are stalwarts of Copenhagen’s index, not Silicon Valley’s next big thing, and the 0.43% expense ratio is the price of admission to a market where the largest companies have been in place for decades. The issuer’s AI-themed product page is best read as aspirational branding rather than a reflection of the fund’s holdings. (source: Exchange-Traded Funds (ETFs) | iShares UK - BlackRock, https://www.ishares.com/uk/individual/en/products/ai-etfs?switchLocale=y&siteEntryPassthrough=true)

The fund’s mandate is straightforward: track the MSCI Denmark Index, a market-cap-weighted basket of Danish large- and mid-cap stocks. The index is dominated by healthcare (Novo Nordisk alone accounts for roughly a third of the index), financials, and industrials, with minimal exposure to the tech and AI names that dominate headlines. The fund’s replication method is physical, meaning it owns the underlying stocks rather than using swaps or derivatives, which is standard for broad-market ETFs but does little to differentiate EDEN from its peers. (source: iShares official ETF centre, https://www.ishares.com/)

The expense ratio of 0.43% is the fund’s headline cost, but the issuer’s disclosure makes clear that most of the protections provided by the UK regulatory system do not apply to EDEN. If BlackRock or its service providers fail, investors are left with the fund’s assets and whatever recourse the fund’s domicile allows-hardly the ironclad safety net implied by the issuer’s marketing. The fund’s AUM and liquidity are secondary to the structure: EDEN trades on Nasdaq Copenhagen and Nasdaq Stockholm, with daily volumes that reflect its niche focus. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/eden; Exchange-Traded Funds (ETFs) | iShares UK - BlackRock, https://www.ishares.com/uk/individual/en/products/etf-investments)

The SEC filings for EDEN confirm the fund’s replication strategy and index tracking, but they do not disclose any material changes to holdings or methodology in recent periods. The fund’s tracking error is a function of the index’s composition and the cost of replication, not issuer discretion. Investors seeking Danish exposure via EDEN get what the MSCI Denmark Index delivers-period. The issuer’s AI angle is a marketing overlay, not a fundamental shift in the fund’s holdings. (source: SEC EDGAR fund search for EDEN, https://www.sec.gov/edgar/search/#/q=EDEN)

The fund’s listing pages on Nasdaq provide real-time quotes and basic metadata, but they do not offer a window into the fund’s internal mechanics beyond what’s disclosed in the prospectus. For a fund this narrow, liquidity is a function of the underlying stocks’ trading volumes and the index’s concentration risk. The top five holdings account for roughly two-thirds of the index, so any shift in Novo Nordisk’s price or Danske Bank’s earnings can move the fund more than broad-market catalysts. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/eden)